Comparison of the effect of oral progesterone and vaginal progesterone on luteal phase support
Phase 3
- Conditions
- In vitro fertilization.
- Registration Number
- IRCT20211101052938N1
- Lead Sponsor
- Zanjan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 160
Inclusion Criteria
IVF/ICSI candidate with history of infertility
age between 18 to 40 years old
have an informed consent to participate in the study
Exclusion Criteria
drug reaction history to one of the drugs used in this study
endocrine or metabolic disorders
endometriosis
Azospermia of partner
uterine anatomic anomaly
history of 2 or more unsuccessful IVF or FET
history of repetitive spontaneous abortion
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Percent of successful pregnancy following in vitro fertilization. Timepoint: Evaluating the outcome of pregnancies at the end of the study. Method of measurement: Recording the successful and unsuccessful pregnancy.
- Secondary Outcome Measures
Name Time Method